andreu soldevila

CEO at Syna Therapeutics
  • Claim this Profile
Contact Information
Location
Greater Barcelona Metropolitan Area, ES
Languages
  • Catalan, Spanish, French, English -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Spain
    • Biotechnology Research
    • 1 - 100 Employee
    • CEO
      • Jan 2018 - Present

      Development of Biosimilarswww.synatherapeutics.com Development of Biosimilarswww.synatherapeutics.com

    • Spain
    • Biotechnology Research
    • 1 - 100 Employee
    • Chairman and Founder
      • Apr 2014 - Present

    • CEO
      • Apr 2014 - Jan 2023

      Lean Bioproduction concept in CMC for biotechnology and Biopharmaceutical products, Bioprocess development, Analytical development and manufacturing of New Biological entities and Biosimilars . www.leanbiopro,com

    • Spain
    • Biotechnology Research
    • 200 - 300 Employee
    • R&D Head of Department
      • Dec 2010 - Apr 2014

      PEGylated Biosimilar, Monoclonal antibodies Biosimilars, Monoclonal Antibody drug conjugate(ADC), Human and veterinary Vaccines, Virus, New Biological entities and Bio-based molecules synthesisParticipating in laboratory design, equipment acquisition and building Process development team.Areas of expertise: Biosimilars, Cell line development, Process and Analytical development.Business development, Project management and Technology Transfer PEGylated Biosimilar, Monoclonal antibodies Biosimilars, Monoclonal Antibody drug conjugate(ADC), Human and veterinary Vaccines, Virus, New Biological entities and Bio-based molecules synthesisParticipating in laboratory design, equipment acquisition and building Process development team.Areas of expertise: Biosimilars, Cell line development, Process and Analytical development.Business development, Project management and Technology Transfer

    • France
    • Retail Office Equipment
    • Protein Bio-Analysis Head of department
      • 2008 - 2010

      Developed a Bioanalysis platform for the characterization and quantitation of Biotherapeutics for Tox and PK-PD studies in the preclinical and clinical trials.Long-term release formulation, stability studies, Bioanalysis, Mass spectrometry and Immunology methods, High throughput analysis Developed a Bioanalysis platform for the characterization and quantitation of Biotherapeutics for Tox and PK-PD studies in the preclinical and clinical trials.Long-term release formulation, stability studies, Bioanalysis, Mass spectrometry and Immunology methods, High throughput analysis

    • United States
    • Research Services
    • Coordinator of the Biotechnology department
      • 1999 - 2008

      Research and development of small molecules by means of biocatalysis, biotransformation and biosynthesis strategiesMicrobiology tests in the GLP development of new moleculesMicrobiology test validation of the pharmaceutical pilot plant Teaching of Microbiology and Biotechnology in different MsC Research and development of small molecules by means of biocatalysis, biotransformation and biosynthesis strategiesMicrobiology tests in the GLP development of new moleculesMicrobiology test validation of the pharmaceutical pilot plant Teaching of Microbiology and Biotechnology in different MsC

Education

  • Universitat Autònoma de Barcelona
    PhD, Biotechnology
    1999 - 2004
  • UVIC
    "BS", Biotechnology
    -
  • manel blancafort
    -
  • manel blancafort
    -
  • manel blancafort
    -

Community

You need to have a working account to view this content. Click here to join now